Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts
Luke F. Peterson, Anita Boyapati, E. Ahn, et al.
Blood (2007) Vol. 110, Iss. 3, pp. 799-805
Open Access | Times Cited: 114

Showing 26-50 of 114 citing articles:

t(8;21)(q22;q22) fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression
Akiko Okumura, Luke F. Peterson, Fumihiko Okumura, et al.
Blood (2008) Vol. 112, Iss. 4, pp. 1392-1401
Open Access | Times Cited: 42
Aberrant expression of CD19 in AML with t(8;21) involves a poised chromatin structure and PAX5
Korden Walter, Peter N. Cockerill, Rachael Barlow, et al.
Oncogene (2010) Vol. 29, Iss. 20, pp. 2927-2937
Closed Access | Times Cited: 37
Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors
Nicolas Duployez, Christophe Willekens, Alice Marceau‐Renaut, et al.
Expert Review of Hematology (2014) Vol. 8, Iss. 1, pp. 43-56
Closed Access | Times Cited: 31
Acute myeloid leukemia harboring t(8;21)(q22;q22): a heterogeneous disease with poor outcome in a subset of patients unrelated to secondary cytogenetic aberrations
Pei Lin, Lei Chen, Rajyalakshmi Luthra, et al.
Modern Pathology (2008) Vol. 21, Iss. 8, pp. 1029-1036
Closed Access | Times Cited: 37
Cooperation between RUNX1-ETO9a and Novel Transcriptional Partner KLF6 in Upregulation of Alox5 in Acute Myeloid Leukemia
Russell C. DeKelver, Benjamin Lewin, Kentson Lam, et al.
PLoS Genetics (2013) Vol. 9, Iss. 10, pp. e1003765-e1003765
Open Access | Times Cited: 27
Integrative genetic analysis of mouse and human AML identifies cooperating disease alleles
Megan Hatlen, Kanika Arora, Vladimir Vacic, et al.
The Journal of Experimental Medicine (2015) Vol. 213, Iss. 1, pp. 25-34
Open Access | Times Cited: 25
Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors
Pavel Spirin, Timofey Lebedev, N. S. Orlova, et al.
Oncotarget (2017) Vol. 8, Iss. 34, pp. 56991-57002
Open Access | Times Cited: 25
Multivalent Binding of the ETO Corepressor to E Proteins Facilitates Dual Repression Controls Targeting Chromatin and the Basal Transcription Machinery
Chun Guo, Qiande Hu, Chunxia Yan, et al.
Molecular and Cellular Biology (2009) Vol. 29, Iss. 10, pp. 2644-2657
Open Access | Times Cited: 30
Chromosomal Minimal Critical Regions in Therapy-Related Leukemia Appear Different from Those of De Novo Leukemia by High-Resolution aCGH
Nathalie Itzhar, Philippe Dessen, Saloua Toujani, et al.
PLoS ONE (2011) Vol. 6, Iss. 2, pp. e16623-e16623
Open Access | Times Cited: 26
JAK inhibitors suppress t(8;21) fusion protein-induced leukemia
M-C Lo, Luke F. Peterson, Mingzhu Yan, et al.
Leukemia (2013) Vol. 27, Iss. 12, pp. 2272-2279
Open Access | Times Cited: 25
Minimal residual disease monitoring in t(8;21) acute myeloid leukemia based on RUNX1‐RUNX1T1 fusion quantification on genomic DNA
Nicolas Duployez, Olivier Nibourel, Alice Marceau‐Renaut, et al.
American Journal of Hematology (2014) Vol. 89, Iss. 6, pp. 610-615
Open Access | Times Cited: 23
Modeling interactions between leukemia‐specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core‐binding factor leukemias
Dan Jones, Hui Yao, Angela Romans, et al.
Genes Chromosomes and Cancer (2009) Vol. 49, Iss. 2, pp. 182-191
Open Access | Times Cited: 26
Effector Caspases and Leukemia
Ying Lu, Guoqiang Chen
International Journal of Cell Biology (2011) Vol. 2011, pp. 1-8
Open Access | Times Cited: 24
In Vitro Functional Study of miR-126 in Leukemia
Zejuan Li, Jianjun Chen
Methods in molecular biology (2010), pp. 185-195
Closed Access | Times Cited: 24
Negative effects of GM-CSF signaling in a murine model of t(8;21)–induced leukemia
Shinobu Matsuura, Ming Yan, Miao-Chia Lo, et al.
Blood (2012) Vol. 119, Iss. 13, pp. 3155-3163
Open Access | Times Cited: 23
Lineage-inappropriate PAX5 expression in t(8;21) acute myeloid leukemia requires signaling-mediated abrogation of polycomb repression
Debleena Ray, So Yeon Kwon, Hiromi Tagoh, et al.
Blood (2013) Vol. 122, Iss. 5, pp. 759-769
Open Access | Times Cited: 21
Core Binding Factor Leukemia: Chromatin Remodeling Moves Towards Oncogenic Transcription
Alessandro Beghini
Cancers (2019) Vol. 11, Iss. 12, pp. 1973-1973
Open Access | Times Cited: 18
Multi-sites cleavage of leukemogenic AML1-ETO fusion protein by caspase-3 and its contribution to increased apoptotic sensitivity
Yong‐Jie Lu, Z-G Peng, T-T Yuan, et al.
Leukemia (2007) Vol. 22, Iss. 2, pp. 378-386
Closed Access | Times Cited: 26
Molecular characterisation of a recurrent, semi‐cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia
N Foster, Kajsa Paulsson, Mark Sales, et al.
British Journal of Haematology (2010) Vol. 148, Iss. 6, pp. 938-943
Open Access | Times Cited: 22
Characterization of a t(5;8)(q31;q21) translocation in a patient with mental retardation and congenital heart disease: implications for involvement of RUNX1T1 in human brain and heart development
Litu Zhang, Zeynep Tümer, Kjeld Møllgård, et al.
European Journal of Human Genetics (2009) Vol. 17, Iss. 8, pp. 1010-1018
Open Access | Times Cited: 21
AML1/ETO Proteins Control POU4F1/BRN3A Expression and Function in t(8;21) Acute Myeloid Leukemia
Jenny Dunne, Duncan M. Gascoyne, T. Andrew Lister, et al.
Cancer Research (2010) Vol. 70, Iss. 10, pp. 3985-3995
Open Access | Times Cited: 20
Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential
Russell C. DeKelver, Ming Yan, E. Ahn, et al.
Blood (2013) Vol. 121, Iss. 18, pp. 3714-3717
Open Access | Times Cited: 19
RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1
Kanagaraju Ponnusamy, Nicole Kohrs, Anetta Ptasinska, et al.
Oncogenesis (2015) Vol. 4, Iss. 4, pp. e146-e146
Open Access | Times Cited: 17
The acute myeloid leukemia associated AML1-ETO fusion protein alters the transcriptome and cellular progression in a single-oncogene expressing in vitro induced pluripotent stem cell based granulocyte differentiation model
Esther Tijchon, Guoqiang Yi, Amit Mandoli, et al.
PLoS ONE (2019) Vol. 14, Iss. 12, pp. e0226435-e0226435
Open Access | Times Cited: 16
Two cell lines of t(8;21) acute myeloid leukemia with activating KIT exon 17 mutation: models for the ‘second hit’ hypothesis
Heiko Becker, Dietmar Pfeifer, Jesús Duque Afonso, et al.
Leukemia (2008) Vol. 22, Iss. 9, pp. 1792-1794
Closed Access | Times Cited: 20

Scroll to top